These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17222171)

  • 1. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
    Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
    Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Felmeden DC; Blann AD; Beevers DG; Lip GY
    J Intern Med; 2004 Jan; 255(1):59-67. PubMed ID: 14687239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
    J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1077-83. PubMed ID: 16363252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.